Skip to content

Cognitive Impairement In Frontotemporal Dementia

Cognitive Impairement In Frontotemporal Dementia

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03452956
Enrollment
997
Registered
2018-03-02
Start date
2003-07-01
Completion date
2020-07-15
Last updated
2020-11-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Frontotemporal Degeneration, Multiple System Atrophy, Progressive Supranuclear Palsy

Brief summary

This is an observational study that aims to better understand the genetic causes of frontotemporal degeneration (FTD), Multiple Systems Atrophy (MSA), and Progressive Supranuclear Palsy (PSP). It is hoped the information gathered in this study will help lead to better diagnostics and future treatments.

Detailed description

Comparative and longitudinal studies reveal clinical differences between subgroups of patients with frontotemporal dementia (FTD), including Progressive Non-fluent Aphasia (PNFA), Semantic Dementia (SD), patients with a disorder of social comportment and personality (SOC), and non-aphasic patients with executive dysfunction (EXEC). MRI studies of cortical atrophy and fMRI studies show correlated neural defects in FTD subgroups. The investigators will obtain converging evidence from multiple sources to test hypotheses about the neural basis for cognitive functions such as semantic memory, grammatical processing, and social functioning in these FTD subgroups, while improving clinical care for these patients. Recent studies have linked progressive supra nuclear palsy (PSP) and multiple systems atrophy (MSA) to FTD. The investigators will obtain comparable neuropsychological and biomarker data in order to compare these patient groups.

Interventions

OTHERNone-Observation Only

No intervention-this is an observational study

Sponsors

University of Pennsylvania
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum

Inclusion criteria

* Individuals who have been diagnosed with FTD, PSP, and MSA

Exclusion criteria

* Individuals under 18 years of age * People with pacemakers or certain metallic implants * pregnant women

Design outcomes

Primary

MeasureTime frameDescription
ProgressionThis is a natural history study - participants are followed from date of enrollment until death, withdrawl, or funding is no longer available, or until 984 months have passedChanges over time in MRI and cognitive testing data.

Secondary

MeasureTime frameDescription
Impaired semantic memory in Semantic Dementia (SD).This is a natural history study - participants are followed from date of enrollment until death, withdrawl, or funding is no longer available, or until 984 months have passedThe impact of cortical atrophy on language processing.

Other

MeasureTime frameDescription
Effortful speech in Progressive Nonfluent Aphasia (PNFA)This is a natural history study - participants are followed from date of enrollment until death, withdrawl, or funding is no longer available, or until 984 months have passedSpeech samples related to cortical atrophy seen on MRI and fMRI studies of verb past tense inflection.
Social disinhibition and rule violation in FTDThis is a natural history study - participants are followed from date of enrollment until death, withdrawl, or funding is no longer available, or until 984 months have passedRelationship of cognitive testing and MRI data and changes over time.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026